StonvexLoading…
StonvexStonvexStonvexCore line items from SOLV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.01B | $8.32B | $6.33B | $4.23B |
Operating Income | $81.00M | $2.18B | $2.06B | $367.00M |
Net Income | $13.00M | $1.56B | $1.49B | $227.00M |
EPS (Diluted) | $0.07 | $8.88 | $8.53 | $1.30 |
Total Assets | $14.10B | $14.29B | $13.97B | $15.07B |
Total Liabilities | $9.13B | $9.24B | $8.99B | $11.43B |
Cash & Equivalents | $561.00M | $878.00M | $1.64B | $492.00M |
Free Cash Flow OCF − CapEx | $-273.00M | $-10.00M | $-42.00M | $-21.00M |
Shares Outstanding | 173.53M | 173.49M | 173.44M | 173.39M |